Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

LRR, Leucine rich repeats

LRR leucine-rich repeat NARP/MILS neuropathy, ataxia, retinitis pigmentosa/maternally... [Pg.965]

F. 7 PARKS LRRK2 structure tuid mutations. ANK, ankyrin repeat region LRR, leucine-rich repeat domain ROC, Ras of complex COR, C-terminal of Ras (GTPase) (Tan et al., 2(X)7). Scale is approximate... [Pg.717]

Sequence motifs [33330 ANK (ANKyrin-like) repeats AAA (ATPases associated with a variety of cellular activities) domain or CAD (conserved ATPase domain) with Walker A and B motifs KEKE (motif rich in alternating lysine (K) and glutamate (E) residues) cys box of UBPs (ubiquitin-processing enzymes) nun- LRR (leucine-rich repeat)-like motif [ZD MPN (found in Mprland Padl in the N terminus) motif ISSSSSSS PCI (for proteasome, COP9andinitiation factor 3) motif H UCH (ubiquitin C-terminal hydrolases) block. [Pg.210]

Figure 18.3 The mammalian lAP family. The distinct domains are shown for each lAP. (BIR—baculovirus lAP repeat CARD-caspase activation recruitment domain RING—really interesting new gene zinc finger LRR—leucine rich repeat NOD-nucleotide-binding oligomerization domain). Figure 18.3 The mammalian lAP family. The distinct domains are shown for each lAP. (BIR—baculovirus lAP repeat CARD-caspase activation recruitment domain RING—really interesting new gene zinc finger LRR—leucine rich repeat NOD-nucleotide-binding oligomerization domain).
Abbreviations TF = transcription factor — =has role in LRR = leucine-rich-repeat GPCR = G-protein-coupled receptor NCAM = neural adhesion molecule ... [Pg.185]

LRR leucine-rich repeat (amino acid/protein)... [Pg.5]

At least 12 ditferent TLRs have so far been identified in mammals (Uematsu and Akria 2007). TLRs are type I transmembrane PRRs that possess an extracellular domain contaiiung leucine-rich repeats (LRR), a transmembrane domain, and an... [Pg.208]

The crystal structure of one LRR protein, the RNAse inhibitor, has revealed that leucine-rich repeats correspond to p-a structural units. This units are arranged for a parallel p-sheet with one surface exposed to solvent so that the protein acquires an unusual non-globular shape, which may be responsible for proteinbinding functions [57]. [Pg.196]

A third myelin inhibitory protein, OMgp, is a GPI-linked protein expressed by oligodendrocytes [18], OMgp is a relatively minor component of myelin, believed to be localized to the paranodal loops, next to the node of Ranvier. OMgp contains a leucine-rich repeat (LRR) domain and a C-terminal domain with serine/threonine repeats. Like MAG, OMgp is also found in the PNS. Like Nogo, OMgp is also expressed in adult neurons. [Pg.523]

The R proteins, which act as receptors for Avr, and other elicitor proteins, are usually leucine-rich-repeat proteins with a characteristic nucleotide binding site attached (NB-LRR proteins).534,537 Like other cell surface receptors they participate in signaling and utilize both ion channels and Ser/Thr protein kinases.538 The Arabidopsis genome contains 150 sequences that may represent NB-LRR receptors.530... [Pg.1869]

Leucine-rich repeats represent binding motifs found in a wide variety of both plant and mammalian proteins (Kobe and Kajava, 2001). These are involved in a multitude of protein-protein interactions. The sequence of porcine ribonuclease inhibitor, for example, displays a leucine-rich repeat (LRR) of length 27-29 residues that occurs 15 times in tandem (Fig. 9). Likewise, the family of small leucine-rich proteoglycans that includes biglycan, decorin, epiphycan, fibromodulin, keratocan, and lumican... [Pg.29]

Fig. 9. The conformation adopted by a leucine-rich repeat (LRR) is that of a /9-strand followed by an o-helix. In porcine ribonuclease inhibitor, a /9-strand (residues 2-8) is connected to an o-helix (residues 14—27) by a connecting loop (residues 9-13). A horseshoe-shaped structure is formed and is exemplified in the crystal structure of ribonuclease inhibitor (PDB 1A4Y Kobe and Deisenhofer, 1993). This has an inner concave surface formed by curved /9-sheets and an outer convex surface formed by oh el ices. The leucines and other large apolar residues form the hydrophobic core of the structure. Fig. 9. The conformation adopted by a leucine-rich repeat (LRR) is that of a /9-strand followed by an o-helix. In porcine ribonuclease inhibitor, a /9-strand (residues 2-8) is connected to an o-helix (residues 14—27) by a connecting loop (residues 9-13). A horseshoe-shaped structure is formed and is exemplified in the crystal structure of ribonuclease inhibitor (PDB 1A4Y Kobe and Deisenhofer, 1993). This has an inner concave surface formed by curved /9-sheets and an outer convex surface formed by oh el ices. The leucines and other large apolar residues form the hydrophobic core of the structure.
RNA-binding activity. The other sub-domain is a leucine-rich repeat (LRR) domain. LRR does not show general RNA-binding activity, but it is required for specific binding to the CTE. Recognition of CTE... [Pg.244]

Figure 13.3 Domain organization of Tap. Human Tap is a 619-amino acids protein. The minimal CTE-binding domain is composed of two globular sub-domains (the ribonucleprotein or RNP domain and the leucine-rich repeat or LRR) and a flexible N-terminal region. Also shown is the localization of the C-terminal nucleocytoplasmic shuttling domain, the cargo-binding domain, and the NTF2-like domain that exhibits pi5 binding activity. Figure 13.3 Domain organization of Tap. Human Tap is a 619-amino acids protein. The minimal CTE-binding domain is composed of two globular sub-domains (the ribonucleprotein or RNP domain and the leucine-rich repeat or LRR) and a flexible N-terminal region. Also shown is the localization of the C-terminal nucleocytoplasmic shuttling domain, the cargo-binding domain, and the NTF2-like domain that exhibits pi5 binding activity.
Matsushima, N., Tanaka, T., Enkhbayar, P., Mikami, T., Taga, M., Yamada, K., Kuroki, Y. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 8 (2007) 124. [Pg.319]


See other pages where LRR, Leucine rich repeats is mentioned: [Pg.191]    [Pg.201]    [Pg.304]    [Pg.191]    [Pg.201]    [Pg.304]    [Pg.1023]    [Pg.1207]    [Pg.1207]    [Pg.25]    [Pg.198]    [Pg.202]    [Pg.237]    [Pg.238]    [Pg.192]    [Pg.369]    [Pg.61]    [Pg.277]    [Pg.48]    [Pg.242]    [Pg.383]    [Pg.398]    [Pg.308]    [Pg.394]    [Pg.14]    [Pg.24]    [Pg.76]    [Pg.92]   


SEARCH



Leucine-rich repeat domains LRRs)

© 2024 chempedia.info